Clinical outcomes of eslicarbazepine acetate monotherapy for focal‐onset seizures: A multicenter audit

Abstract

To assess the effectiveness and tolerability of eslicarbazepine acetate (ESL) monotherapy in routine clinical practice for the treatment of focal‐onset seizures.